New platform for childhood cancer medicines counters ‘unacceptable imbalance’ in survival rates
The Global Platform for Access to Childhood Cancer Medicines, launched by the World Health Organization (WHO) and St. Jude Children’s Research Hospital in the United States, seeks to counter an “unacceptable imbalance” in survival rates. It offers an innovative approach in cancer care by addressing medicine availability in low and middle-income countries, which WHO said is often complicated by higher…
Read More
